Skip to main content
SpringerLink
Log in

Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Lipid peroxidation (LPx) products were measured as thiobarbituric acid-reactive substances (TS) and lipid-soluble fluorescent pigments (FP) in both plasma and CSF from MS patients and controls. Although no significant changes were found in MS plasma, we report here for the first time increases in both TS and FP in MS CSF (p<0.05 and p<0.01, respectively, compared with patients with other neurological diseases), indicating that increased LPx in CNS may be a feature of MS. Levels of transferrin were normal but caeruloplasmin (CP), a major antioxidant plasma protein, was significantly raised in MS patients (p<0.01) and this may represent an adaptive response to increased oxidative challenge. Neither of these proteins was detectable in CSF using radial immunodiffusion. There was no significant correlation between the severity or duration of the disease nor the period since the last relapse and either LPx products of CP suggesting that the changes observed in this work are not simply the direct result of demyelination and tissue damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hunter, M. I. S., Lao, M. S., Burtles, S. S., andDavidson, D. L. W. 1984. Erythrocyte antioxidant enzymes in multiple sclerosis and the effect of hyperbaric oxygen. Neurochem. Res. 9:507–516.

    Article  PubMed  Google Scholar 

  2. Kurantsin-Mills, J., Samji, N., Moscarello, M. A., andBoggs, J. M. 1982. Comparison of membrane structure, osmotic fraglity and morphology of multiple sclerosis and normal erythrocytes. Neurochem. Res. 7:1523–1540.

    Article  PubMed  Google Scholar 

  3. Caspary, E. A., Sewell, F., andField, E. J. 1967. Red blood cell fragility in multiple sclerosis. Brit. Med. J. 2:610–611.

    PubMed  Google Scholar 

  4. Schauf, C. L., Frischer, H., andDavis, F. A. 1980. Mechanical fragility of erythrocytes in multiple sclerosis. Neurology 30:323–325.

    PubMed  Google Scholar 

  5. Shukla, V. K. S., Jensen, G. E., andClausen, J. 1977. Erythrocyte glutathione peroxidase deficiency in multiple sclerosis. Acta Neurol. Scand. 56:542–550.

    PubMed  Google Scholar 

  6. Szeinberg, A., Golan, R., Ezzer, J. B., Sarova-Pinhas, I., andKindler, D. 1981. Decreased erythrocyte glutathione peroxidase activity in multiple sclerosis. Acta Neurol. Scand. 60:265–271.

    Google Scholar 

  7. Szeinberg, A., Golan, R., Ben-Ezzer, J., Sarova-Pinhas, I., andKindler, D. 1981. Glutathione peroxidase activity in various types of blood cell in multiple sclerosis. Acta Neurol. Scand. 63:67–75.

    PubMed  Google Scholar 

  8. Jensen, G. E., Gissel-Neilsen, G., andClausen, J. 1980. Leukocyte glutathione peroxidase E.C.1.11.1.9 activity and selenium level in multiple sclerosis. J. Neurol. Sci. 48:61–68.

    Article  PubMed  Google Scholar 

  9. Jensen, G. E., andClausen, J. 1984. Glutathione peroxidase and reductase, glucose-6-phosphate dehydrogenase and catalase activities in multiple sclerosis. J. Neurol. Sci. 63:45–53.

    Article  PubMed  Google Scholar 

  10. Zachara, B., Gromadzinska, J., Czernicki, J., Maciejek, Z., andChmielewski, H. 1984. Red blood cell glutathione peroxidase activity in multiple sclerosis. Klin. Wochenschr. 62:179–182.

    PubMed  Google Scholar 

  11. Polidoro, G., Di Ilio, C., Arduini, A., La Rovere, G., andFederici, G. 1984. Superoxide dismutase, reduced glutathione and thiobarbituric acid-reactive products in erythrocytes of patients with multiple sclerosis. Int. J. Biochem. 16:505–509.

    Article  PubMed  Google Scholar 

  12. Rogovina, N. I., andKoklov, A. P. 1980. Metabolism of lipid peroxidation products in multiple sclerosis patients. Zh. Nevropatol. Paikhiatr. Im. S. S. Korsakova 80:696–700.

    Google Scholar 

  13. Yu, R. K., Ueno, K., Glaser, G. H., andTourtellotte, W. W. 1982. Lipid and protein alterations of spinal cord and cord myelin of multiple sclerosis. J. Neurochem. 39:464–477.

    PubMed  Google Scholar 

  14. Woelk, H., andBorri, P. 1973. Lipid and fatty acid composition of myelin purified from normal and MS brains. Eur. Neurol. 10:250–260.

    PubMed  Google Scholar 

  15. Gopfert, E., Pytlik, S., andDebuch, H. 1980. 2′,3′-Cyclic nucelotide 3′-phosphohydrolase and lipids of myelin from multiple sclerosis and normal brains. J. Neurochem. 34:732–739.

    PubMed  Google Scholar 

  16. Thompson, R. H. S. 1975. Unsaturated fatty acids in multiple sclerosis. Pages 184–191.In Davison, A. N., Humphrey, J. H., Liversedge, L. A., McDonald, W. I., andPorterfield, J. S. (eds). Multiple sclerosis research. HMSO: London.

    Google Scholar 

  17. Baker, R. W. R., Thompson, R. H. S., andZilkha, K. J. 1964. Serum fatty acids and multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 27:408–414.

    PubMed  Google Scholar 

  18. Sanders, H., Thompson, R. H. S., Wright, H. P., andZilkha, K. J. 1968. Further studies on platelet adhesion and serum cholesteryl linoleate levels in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 31:321–325.

    PubMed  Google Scholar 

  19. Neu, I. S. 1983. Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients. Acta Neurol. Scand. 67:151–163.

    PubMed  Google Scholar 

  20. Gul, S., Smith, A. D., Thompson, R. H. S., Wright, H. P., andZilkha, K. J. 1970. Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 33:506–510.

    PubMed  Google Scholar 

  21. Cherayil, G. D. 1984. Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis. J. Neurol. Sci. 63:1–10.

    Article  PubMed  Google Scholar 

  22. Bernsohn, J., andStephanides, L. M. 1967. Aetiology of multiple sclerosis. Nature 215:821–823.

    PubMed  Google Scholar 

  23. Dick, G. 1976. The aetiology of multiple sclerosis. Proc. Roy. Soc. Med. 69:611–615.

    PubMed  Google Scholar 

  24. Jones, R., Preece, A. W., Luckman, N. P., andForrester, J. A. 1983. The analysis of the red blood cell unsaturated fatty acid test for multiple sclerosis using laser cytopherometry. Phys. Med. Biol. 28:1145–1151.

    Article  PubMed  Google Scholar 

  25. Mertin, J., andMeade, C. J. 1977. Relevance of fatty acids in multiple sclerosis. Brit. Med. Bull. 33:67–71.

    PubMed  Google Scholar 

  26. Wickstrom, J., Westermark, T., andPalo, J. 1976. Selenium, vitamin E and copper in multiple sclerosis. Acta Neurol. Scand. 54:287–290.

    PubMed  Google Scholar 

  27. Fletcher, B. L., Dillard, C. J., andTappel, A. L. 1973. Measurement of fluorescent lipid peroxidation products in biological systems and tissues. Anal. Biochem. 52:1–9.

    Article  PubMed  Google Scholar 

  28. Al-Timimi, D. J., andDormandy, T. L. 1977. The inhibition of lipid autoxidation by human caeruloplasmin. Biochem. J. 168:283–288.

    PubMed  Google Scholar 

  29. Satoh, K. 1978. Serum lipid peroxide in cerebrovascular disorders detected by a new colorimetric method. Clin. Chim. Acta. 90:37–43.

    Article  PubMed  Google Scholar 

  30. Stocks, J., andDormandy, T. L. 1971. The autoxidation of human red cell lipids induced by hydrogen peroxide. Brit. J. Haematol. 20:95–111.

    Google Scholar 

  31. Dillard, C. J., andTappel, A. L. 1971. Fluorescent products of lipid peroxidation of mitochondria and microsomes. Lipids 6:715–721.

    PubMed  Google Scholar 

  32. Beynon, R. J. 1983. In: Contributed Programs Vol. 1, Biochemistry Microcomputer Group, University of Liverpool.

  33. Halliwell, B., andGutteridge, J. M. C. 1984. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet (i):1396–1397.

    Article  Google Scholar 

  34. Slater, T. F. 1984. Free-radical mechanisms in tissue injury. Biochem. J. 222:1–15.

    PubMed  Google Scholar 

  35. Gutteridge, J. M. C., andStocks, J. 1981. Caeruloplasmin: physiological and pathological perspectives. CRC Crit. Rev. Clin. Lab. Sci. 14:257–329.

    Google Scholar 

  36. Gutteridge, J. M. C., Richmond, R., andHalliwell, B. 1980. Oxygen free radicals and lipid peroxidation. Inhibition by the protein caeruloplasmin. FEBS Lett. 112:269–272.

    Article  Google Scholar 

  37. Bowern, N., Ramshaw, I. A., Clark, I. A., andDoherty, P. C. 1984. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J. Exp. Med. 160:1532–1543.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry and Microbiology, University of St. Andrews, St Andrews, Fife

    M. I. S. Hunter & B. C. Nlemadim

  2. Department of Neurology, Dundee Royal Infirmary, Dundee, Angus

    D. L. W. Davidson

Authors
  1. M. I. S. Hunter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. C. Nlemadim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. L. W. Davidson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hunter, M.I.S., Nlemadim, B.C. & Davidson, D.L.W. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochem Res 10, 1645–1652 (1985). https://doi.org/10.1007/BF00988606

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00988606

Keywords

Search

Navigation